Should we change the target blood pressure in diabetic patients?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Diabetes/Metabolism Research Reviews

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/dmrr.2348PMID 23280860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials

  2011cited by this paper
• Management of blood pressure in patients with diabetes.

  2011cited by this paper
• Blood Pressure: The Lower, the Better

  2011cited by this paper
• Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

  2011cited by this paper
• Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

  2010cited by this paper
• Cardiac Autonomic Neuropathy in Diabetes

  2010cited by this paper
• Effects of medical therapies on retinopathy progression in type 2 diabetes.

  2010cited by this paper
• Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

  2009cited by this paper
• Should We Treat Prehypertension in Diabetes?

  2009cited by this paper
• Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

  2009cited by this paper
• Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007.

  2008cited by this paper
• Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003).

  2008cited by this paper
• Ambulatory Blood Pressure Variability Is Increased in Diabetic Hypertensives

  2008cited by this paper
• Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

  2008cited by this paper
• Telmisartan, ramipril, or both in patients at high risk for vascular events.

  2008cited by this paper
• Telmisartan to prevent recurrent stroke and cardiovascular events.

  2008cited by this paper
• Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

  2007cited by this paper
• Standards of medical care in diabetes.

  2006cited by this paper
• The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

  2005cited by this paper
• Stroke in china.

  2004cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Blood pressure and cardiovascular disease in the Asia Pacific region.

  2003cited by this paper
• Recommendations for special populations: diabetes mellitus and the metabolic syndrome.

  2003cited by this paper
• Blood pressure and cardiovascular disease in the Asia Pacific region

  2003cited by this paper
• Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?

  2003cited by this paper
• Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003

  2003cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.

  2002cited by this paper
• Diabetes mellitus and hypertension: key risk factors for kidney disease.

  2002cited by this paper
• Diabetes, Hypertension, and Cardiovascular Disease: An Update

  2001cited by this paper
• Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

  2000cited by this paper
• Influence of diabetes and type of hypertension on response to antihypertensive treatment.

  2000cited by this paper
• Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

  2000cited by this paper
• Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

  2000cited by this paper
• High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?

  2000cited by this paper
• Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

  1999cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• Hypertension Optimal Treatment (HOT) trial.

  1998cited by this paper
• Hypertension Optimal Treatment (HOT) trial.

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension

  1998cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• Diabetic and Hypertensive Heart Disease

  1996cited by this paper
• Shanghai trial of nifedipine in the elderly (STONE).

  1996cited by this paper
• Stroke in China, 1986 through 1990.

  1995cited by this paper
• Standards of Medical Care for Patients With Diabetes Mellitus

  1993cited by this paper
• Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns.

  1993cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial

  1986cited by this paper
• Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

  1985cited by this paper
• Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians.

  1980cited by this paper
• Letter: Immunotherapy for colorectal cancer.

  1976cited by this paper
• Study Group

  1971cited by this paper
• Diabetes

  1894cited by this paper

• Treating hypertension in type 2 diabetes

  2014cites this paper
• Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol

  2013cites this paper